School of Medicine

Research from WashU Medicine found a possible new treatment strategy for certain types of blood cancers.

Researchers at WashU Medicine have described the neurodegeneration that occurs in the nervous system of the bowel in Batten disease, a rare and fatal genetic condition.

A phase 1 clinical trial co-led by researchers at WashU Medicine found that a new type of cell-based immunotherapy was safe for patients with several types of B-cell lymphoma, a type of blood cancer.

The Internal Medicine Residency Program at WashU Medicine has received the Accreditation Council for Graduate Medical Education 2025 Barbara Ross-Lee, DO Diversity, Equity, and Inclusion Award.

Mice infected with the bacteria that cause tuberculosis (TB) fared better when treated with an experimental compound that modulates immune responses, according to a study led by Christina Stallings, a professor of molecular microbiology at WashU Medicine.

Researchers at Washington University found correlations between types of brain structure and people who try drugs before age 15.

WashU Medicine researchers have been awarded nearly $5 million to better understand what causes pain symptoms to persist in some patients recovering from surgery.

Kory Lavine, MD, PhD, the Alan A. and Edith L. Wolff Professor of Cardiology at WashU Medicine, has received a $600,000 grant from the Additional Ventures Foundation — an organization that funds research into congenital heart disease — to study hypoplastic left heart syndrome.

Gregory Lanza, MD, PhD, the James R. Hornsby Family Professor in Biomedical Sciences at WashU Medicine, has been named a fellow of the National Academy of Inventors in recognition of his application of nanotechnology to a broad variety of medical innovations.

Nusayba Bagegni, MD, an associate professor at WashU Medicine, has been awarded a 2024 Early Career Cancer Clinical Investigator Award from the National Cancer Institute (NCI), part of the National Institutes of Health (NIH).